Arena Pharma (ARNA) Tops Q3 EPS by 4c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. SPCX
2. LEVI
3. SBUX
4. NVDA
5. GOOGL
6. CRGY
7. AAPL
8. SPY
9. APLD
10. ORCL

Go back to Arena Pharma (ARNA) Tops Q3 EPS by 4c

Arena Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2018 Financial Results

November 7, 2018 4:01 PM EST

SAN DIEGO, Nov. 7, 2018 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today provided a corporate update and reported financial results for the third quarter ended September 30, 2018.

"Our recent positive results from the Phase 2a trial of olorinab in pain associated with Crohn's disease and the ralinepag PAH open-label extension trial further demonstrate the strength of Arena's pipeline and the ability of the Company to execute on these potentially transformative programs," said Amit D. Munshi, President and CEO of Arena.... More